Dietary effect of gamma-linolenic acid on the lipid profile of rat fed erucic acid rich oil

This study evaluated the effects of dietary supplementation of gamma-Linolenic acid (18:3n-6, GLA) on the lipid profile of serum and other tissues of rats fed erucic acid (C22:1) rich oil like mustard oil. The rats were fed diet containing 20% mustard oil as erucic acid rich oil and 20% groundnut oil as dietary fat. These groups were kept as reference groups. Another group fed diet containing 20% fat to which evening primrose oil as a source of GLA was blended with mustard oil and groundnut oil at 5% level. The feeding experiment was done for 4 weeks. In another set mustard oil fed group was kept as control while the experimental group was fed evening primrose oil as a source of GLA blended with mustard oil at 2.5% level. The feeding experiment was carried out for 12 weeks. The other dietary components remained same for all the groups. After the scheduled feeding period, it was found that there was no significant change in weight gain, food intake and food efficiency ratio. It was found that dietary GLA resulted in significant decrease in serum triglyceride (TG) and very low density lipoprotein (VLDL) cholesterol and significant increase in high density lipoprotein (HDL) cholesterol in serum in the experimental group. In liver total cholesterol (TC) is significantly higher and in heart and liver TG is significantly lower in GLA fed group.     

Antihypertensive effect and safety of dietary alpha-linolenic acid in subjects with high-normal blood pressure and mild hypertension

We investigated the antihypertensive effect and safety of alpha-linolenic acid (ALA) in human subjects. In Experiment 1, subjects with high-normal blood pressure and mild hypertension ingested bread containing 14 g of common blended oil (control oil) or ALA-enriched oil for 12 weeks. The test oil contained 2.6g/14 g of ALA. The subjects ingested strictly controlled meals during the study period. Systolic blood pressure was significantly lower in the ALA group than in the control group after ingestion of the test diet for 4, 8 and 12 weeks. Diastolic blood pressure was significantly lower in the ALA group than in the control group after ingestion of the test diet for 12 weeks. In Experiment 2, we evaluated the safety of high intake of ALA (7.8 g/d), particularly its effects on oxidation in the body and blood coagulation. Normotensive, high-normotensive and mildly hypertensive subjects ate bread that contained 42 g of the control oil or the test oil for 4 weeks. No significant difference was noted in the lipid peroxide level, high-sensitive C-reactive protein level, plasma prothrombin time or activated partial thromboplastin time between the two groups. No abnormal changes were noted after test diet ingestion on blood test or urinalysis, and no adverse event considered to have been induced by the test oil was observed in Experiment 1 and 2. These results suggest that ALA have an antihypertensive effect with no adverse effect in subjects with high-normal blood pressure and mild hypertension.     

Effects of dietary glucosylceramide on dermatitis in atopic dermatitis model mice

The effects of dietary plant and yeast cerebroside (glucosylceramide), a major sphingolipid in plants and yeast, on atopic dermatitis (AD) like symptoms were investigated in a mouse model. After 7 wk of feeding with a diet containing maize glucosylceramide, plasma IgE levels became significantly lower and in contrast, the levels of interleukin (IL)‐12, which induces cellular immunity, became significantly higher in the AD mice than in the controls. However, the sphingolipid constituents of the skin fraction in the maize glucosylceramide fed group did not contain sphingoid bases of plant origin, such as 8‐unsaturated sphingoid bases. The results of the present study indicated that dietary plant glucosylceramide prevented AD‐like symptoms in AD model mice via regulation of Th1/Th2 balance. Practical applications: Dietary plant and yeast glucosylceramides have been shown to suppress AD‐like symptoms in AD model mice via regulation of helper T‐cell Th1/Th2 balance. Glucosylceramide are capable of preventing AD and may be useful in skincare products.     

Dietary supplementation with ether-linked lipids and tissue lipid composition

The goal of this investigation was to determine the effect of an alkylglycerol dietary supplement on the lipid composition of several major organs. Lipids from kidney, liver, and lung tissues of rats on a laboratory chow diet (controls) were compared to lipids from the same tissues of rats that had received oral supplements (300–600 mg/day) of 1-O-alkyl-2,3-diacetyl-sn-glycerol (alkyl groups were 65% 18∶1 and 17% 16∶1) for six days. Incorporation of the alkylglycerol into tissue lipids was indicated by both the presence of a neutral lipid in liver that had the same chromatographic migration as alkyldiacylglycerols and by a substantial increase (≈150% of controls) in the octadecenyl group of the alk-1-enyl- and alkyl-glycerol side chains derived from total phospholipids of all three tissues. Compared to controls, there was a significant increase in the amount of alkylacylglycerophosphocholine in all three tissues of the alkylglycerol supplemented group. Total lipids, total phospholipid phosphorus, or the distribution of phospholipid classes (except for small differences in lung tissue) were not affected by the dietary supplement. The increase in ether lipids was offset by a corresponding decrease in the diacyl subclass in tissues from animals on the alkyldiacetylglycerol supplement. Our results indicate that the amount of ether-linked glycerolipids in rat tissues can be easily increased with dietary supplements of alkylglycerols.     

Long-chain PUFA supplementation improves PUFA profile in infants with cholestasis

Long-chain PUFA (LCP) deficiency is a frequent complication in cholestatic infants. We investigated the effects of LCP-supplemented formula on EFA status in infants with cholestasis. Twenty-three infants with cholestasis (biliary atresia after surgery, 8; intrahepatic cholestasis, 15) aged 1.9 to 4.9 mon (median 3.1 mon) were randomized to receive commercial infant formulas either without LCP or with LCP from egg phospholipids for 1 mon. Liver tests, nutrient intakes, and plasma phospholipid FA (%w/w) were determined at baseline and after intervention. At baseline, patients had high serum direct bilirubin levels (5.9 ± 3.0 mg/dL; mean ± SD), they were malnourished (body fat mass: 40 ± 13% of normal) and presented with PUFA deficiency [plasma phospholipid PUFA: 28.43%w/w (26.56–30.53) in patients vs. 37.02%w/w (34.53–39.58) in controls; median (1st–3rd quartile)] with elevated Mead acid and palmitoleic acid. LCP-supplemented (n=11 and-nonsupplemented groups (n=12) did not differ in age, indicators of liver function, and EFA status at baseline. After the intervention, LCP-supplemented infants had higher levels of arachidonic acid [7.2 (5.9–8.8) vs. 4.2 (3.0–5.3) %w/w; P<0.001] and DHA [2.8 (2.2–3.2) vs. 1.6 (1.0–2.1) %w/w; P<0.05], accompanied by increased [BARS concentration: 1.9 (1.4–2.2) vs. 1.3 (1.1–1.6) nmol/mL; P<0.05]. We concluded that LCP-supplemented formulae improve LCP status of infants with severe cholestasis but may enhance lipid peroxidation.     

Dietary supplementation with conjugated linoleic acid does not alter the resistance of mice to Listeria monocytogenes infection

Conjugated linoleic acid (CLA) has been used experimentally as a dietary supplement to increase lean body weight and to modulate inflammation in a variety of animal species. In addition, human use of dietary CLA as a supplement to regulate body fat has received both scientific and public attention. No reports have been published regarding the effects of dietary CLA on antimicrobial resistance. In this study, we provide evidence that feeding CLA for up to 4 wk does not alter host defense against Listeria monocytogenes in mice. These findings suggest that the anti-inflammatory effects of CLA do not impair cellular immunity to this intracellular pathogen.     

The occurrence and biosynthesis of gamma-linolenic acid in a blue-green alga,Spirulina platensis

The acyl-lipid and fatty acid composition of six blue-green algae, namely,Spirulina platensis, Myxosarcina chroococcoides, Chlorogloea fritschii, Anabaena cylindrica, Anabaena flos-aquae, and Mastigocladus laminosus is reported. All contain major proportions of mono-and digalactosyl diglyceride, sulfoquinovosyl diglyceride, and phosphatidyl glycerol, but none possess lecithin, phophatidyl ethanolamine, or phosphatidyl inositol. Trans-3-hexadecenoic acid was absent from all extracts. The analyses provide further evidence that there is no general chemical or physical requirement for any specific fatty acid in photosynthesis. S. platensis is unique among photoautotrophic organisms so far studied, containing major quantities of γ-linolenic acid (6,9,12-octadecatrienoic acid). This acid is synthesized by the alga by direct desaturation of linoleic acid and is primarily located in the mono- and digalactosyl diglyceride fractions. The possible phylogenetic relationship betweenS. platensis and other plant forms is discussed.     

A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects

In this long-term study, we wanted to explore the effect of dietary supplementation of seal oil (SO) as compared cod-liver oil (CLO) on subjects with moderate hypercholesterolemia. The test parameters included fatty acid composition in serum, blood lipids, platelet aggregation, and the activity of blood monocytes. After a run-in period of 6 mon, 120 clinically healthy hypercholesterolemic (7.0–9.5 mmol/L; 270–366 mg/dL) subjects were randomly selected to consume either 15 mL of SO or CLO daily for 14 mon followed by a 4-mon wash-out period. A third group was not given any dietary supplement (control). Consumption of marine oils (SO and CLO) changed the fatty acid composition of serum significantly. Maximal levels were achieved after 10 mon. No further changes were seen after 14 mon. A wash-out period of 4 mon hardly altered the level of n−3 fatty acids in serum. Addition of SO gave 30% higher level of eicosapentaenoic acid, as compared to CLO. Subjects taking SO or CLO had lower whole-blood platelet aggregation than the control group. Neither SO nor CLO had any effects on the levels of serum total cholesterol, high-density lipoprotein cholesterol, postprandial triacylglycerol, apolipoproteins A1 and B100, lipoprotein (a), monocyte function expressed as monocyte-derived tissue factor expression, and tumor necrosis factor.     

Supplementation with evening primrose oil in atopic dermatitis: Effect on fatty acids in neutrophils and epidermis

We investigated the effect of oral supplementation with evening primrose oil, containing 72% linoleic acid (18∶2n−6) and 10% γ-linolenic acid (18∶3n−6), on the epidermal and neutrophil phospholipid fatty acid composition in 15 patients with atopic dermatitis (AD). Three different dose levels, 4, 8 and 12 capsules per day containing 0.5 g oil, were given to three groups of patients. The only n−6 fatty acid showing a significant (p<0.05) dose-related increase was dihomo-γ-linolenic acid (20∶3n−6) in neutrophil phospholipids. The highest dose increased dihomo-γ-linolenic acid by 45% in neutrophil phospholipids, by 46% in lesion-free epidermal phosphatidylcholine, and by 15% in lesion-free epidermal phosphatidylethanolamine. In both lesional and lesion-free epidermis, supplementation resulted in a rise in the ratio between n−6 and monounsaturated fatty acids, reaching significance (p<0.05) in lesional epidermis. This study shows that moderate and favorable fatty acid changes can be obtained in the epidermis of AD patients, when given 6 g per day of oil rich in n−6 fatty acids. The abnormal lipid and fatty acid pattern of the atopic epidermis may be involved in the pathogenesis of the disease, and should therefore be the target for future therapeutic approaches with fatty acid supplements.     

Dietary protein supplementation. Fundamentals and examples of practical application

Involving the most expensive of all the nutrients required by the body, the biological utilization of dietary protein remains an important topic, particularly to Third World countries wherein protein supplies are frequently limited. Protein supplementation of cereals and other foodstuffs is often used as a means of increasing protein intake. Supplementation not only increases protein intake but often also changes the physiological usability of the protein component of the resultant mixture. Employing an updated biological method for assessment of protein nutritive value, the author investigated the nature of the change in protein assimilability as a result of graded changes in the proportions of certain proteins combined pairwise into single mixtures. Data are presented on the basis of which the digestibility and/or assimilability of the protein component of a given mixture can be estimated. Lastly, the author indicates the need to evaluate high-protein foods and protein supplements in terms of, not only protein content relative to cost, but also of inherent nutritive value and complementary effect.     

Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function

The purpose of this study was to examine if conjugated linoleic acid (CLA) supplementation of diets would alter fatty acid (FA) composition and function of peripheral blood mononuclear cells (PBMC). Seventeen women, 20–41 yr, participated in a 93-d study conducted at the Metabolic Research Unit. The same diet (19, 30, and 51% energy from protein, fat, and carbohydrate, respectively) was fed to all subjects throughout the study. Seven subjects (control group) supplemented their diet with six daily capsules (1 g each) of placebo oil (sunflower) for 93 d. For the other 10 subjects (CLA group), the supplement was changed to an equivalent amount of Tonalin capsules for the last 63 d of the study. Tonalin provided 3.9 g/d of a mixture of CLA isomers (trans-10,cis-12, 22.6%; cis-11,trans-13, 23.6%; cis-9,trans-11, 17.6%; trans-8,cis-10, 16.6%; other isomers 19.6%), and 2.1 g/d of other FA. PBMC isolated on study days 30 and 90 were used to assess intracellular cytokines by flow cytometry, secreted cytokines, and eicosanoid by enzyme-linked immonosorbent assay, and FA composition by gas-liquid chromatography. After supplementation, total CLA concentration increased from 0.012 to 0.97% (P<0.0001) in PBMC lipids, but it did not significantly alter the concentration of other FA. CLA supplementation did not alter the in vitro secretion of prostaglandin E₂, leukotriene B₄, interleukin-1β (IL-1β), or tumor necrosis factor α (TNFα) by PBMC simulated with lipopolysaccharide, and the secretion of IL-2 by PBMC stimulated with phytohemagglutinin. Nor did it alter the percentage T cells producing IL-2, interferon γ, and percentage of monocytes producing TNFα. The intracellular concentration of these cytokines was also not altered. None of the variables tested changed in the control group. Our results show that CLA supplementation increased its concentration in PBMC lipids, but did not alte their functions. Parts of data included here were published as abstracts for the Experimental Biology and AOCS 2001 meetings.     

Dietary CLA and DHA modify skin properties in mice

This study investigated the influence of PUFA on the properties of mouse skin. Mice (3 wk old) were given free access to oils high in linoleic acid, CLA, or DHA for 4 wk. At the end of the experiment, their skins were compared by both biochemical and histological methods. No significant differences in lipid and collagen contents were detected among treatments, although the FA composition in the skin was altered depending upon the FA composition of the supplemented oils. Electron microscopy revealed that the subcutaneous tissue layers in the CLA and DHA groups were significantly thinner than that in the high linoleic acid group, whereas no differences in the thickness of dermis layers were observed among the three groups. These results suggest that skin properties in mice are readily modified by dietary FA sources within 4 wk of dietary oil supplementation.     

Erythrocytes carotenoids after astaxanthin supplementation in middle-aged and senior Japanese subjects

A randomized, double-blind human trial was conducted to assess the effect of 4- or 12-week astaxanthin supplementation (1 or 3 mg/day) on the carotenoid compositions of erythrocytes in Japanese middle-aged and senior subjects. Erythrocyte astaxanthin concentrations after 4- or 12-weeks of supplementation (3 mg/day) was significantly higher than after placebo or 1 mg astaxanthin supplementations. No differences were observed in either the carotenoid compositions or the phospholipid hydroperoxide concentrations in erythrocytes after astaxanthin intake in both the 1 and 3 mg/day groups.     

Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery

The objective of present investigation was to formulate hydrogel containing glycyrrhizic acid loaded Ultra deformable vesicles i.e., transfersomes effective against atopic dermatitis. These were formulated using thin film hydration technique and this transferosomal suspension was loaded into a hydrogel base. This was characterized on the basis of parameters like particle size, shape and surface morphology, in vitro release, in vivo studies and skin deposition studies. The optimized formulation showed the in vitro release of 89.8% upto 24?h and following Higuchi’s equation (R²?=?0.971).The data obtained revealed that the formulation is able to be effective against atopic dermatitis.     

Dietary supplementation with arachidonic and docosahexaenoic acids has no effect on pulmonary surfactant in artificially reared infant rats

Despite the potential use of long-chain polyunsaturated fatty acid (LCPUFA) supplementation to promote growth and neural development of the infant, little is known about potential harmful effects of the supplementation. The present study determined whether supplementation with arachidonic acid (AA) and/or docosahexaenoic acid (DHA) in rat milk formula (RMF) affects saturation of pulmonary surfactant phospholipids (PL). Beginning at 7 d of age, infant rats were artificially fed for 10 d with RMF supplemented with AA at 0, 0.5, and 1.0% of total fatty acid, or supplemented with DHA at 0, 0.5, and 1.0%, or cosupplemented with AA and DHA at levels of 0∶0, 0.5∶0.3, and 1.0∶0.6% of the fat blend. Lung tissue PL contained 43 weight percent palmitate (16∶0) of total fatty acids in infant rats fed the unsupplemented RMF. The supplementation with AA at both 0.5 and 1.0% decreased the weight percentage of 16∶0 and stearate (18∶0), indicating a decrease in saturation of PL. The observed decreases were accompanied by increases in AA and linoleic acid (18∶2n−6). Surfactant phosphatidylcholine (PC) consisted of 71 weight percent 16∶0 in the unsupplemented group, and this highly saturated PC was not altered by the cosupplementation with AA and DHA although there was a slight increase in DHA. Similarly, the cosupplementation did not change fatty acid composition of surfactant PL when compared with the unsupplemented group. The cosupplementation slightly decreased the weight percentage of 16∶0 with a proportional increase in 18∶0 leading to an unchanged weight percentage of total saturated fatty acids. These results suggest that, unlike lung tissue PL, the composition of saturated fatty acids in surfactant PL, particularly PC, is resistant to change by dietary AA and DHA supplementation. This, together with the unchanged concentration of total fatty acids in surfactant PC, indicates that LCPUFA cosupplementation causes no effect on pulmonary surfactant.     

Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores

The utilization of dietary docosahexaenoic acid (DHA; 22:6n−3) as a source of eicosapentaenoic acid (EPA; 20:5n−3) via retroconversion was investigated in both vegetarians and omnivores. For this purpose, an EPA-free preparation of DHA was given as a daily supplement (1.62 g DHA) over a period of 6 wk. The dietary supplement provided for a marked increase in DHA levels in both serum phospholipid (from 2.1 to 7.1 mol% in vegetarians and 2.2 to 7.6 mol% in omnivores) and platelet phospholipid (from 1.1 to 3.4 mol% in vegetarians and 1.4 to 3.9 mol% in omnivores). EPA levels rose to a significant but much lesser extent, while 20:4n−6, 22:5n−6, and 22:5n−3 all decreased. Based on the serum phospholipid data, the retroconversion of DHA to EPA in vivo was estimated to be 9.4% overall with no significant difference between omnivores and vegetarians.     

Multiwalled carbon nanotubes and nanofibers grafted with polyetherketones in mild and viscous polymeric acid

Direct covalent attachment of amorphous and semicrystalline polyetherketones onto the surface of either an as-received multi-walled carbon nanotube (MWNT) or a vapor-grown carbon nanofiber (VGCNF) in polyphosphoric acid (PPA) with optimized P₂O₅ content resulted in uniform grafting of polyetherketones to these carbon nanoscale materials. Soxhlet extraction experiment, the spectra from FT-IR spectroscopy and the clear images from high-resolution transmission electron microscopy showed that the covalent attachment is effective in uniformly coating the PEK grafts on the surfaces of both MWNT and VGCNF. Additionally, a drastic increase in solution viscosity due to the formation of giant molecules was monitored during polymerization. As such, the resulting nanocomposites were easily fabricated via a simple compression molding technique. The alignment possibility of MWNT and VGCNF grafted with semicrystalline PEK in these thermoplastic nanocomposites via solution fiber spinning was also demonstrated.     

Dietary docosahexaenoic acid and immunocompetence in young healthy men

The purpose of this study was to examine the effect of dietary docosahexaenoic acid (DHA), in the absence of eicosapentaenoic acid, on human immune response (IR). A 120-d study with 11 healthy men was conducted at the Metabolic Research Unit of the Western Human Nutrition Research Center. Four subjects (control group) were fed the stabilization or basal diet (15, 30, and 55% energy from protein, fat, and carbohydrate, respectively) throughout the study; the remaining seven subjects (DHA group) were fed the basal diet for the first 30 d, followed by 6 g DHA/d for the next 90 d. DHA replaced an equivalent amount of linoleic acid; the two diets were comparable in their total fat and all other nutrients. Both diets were supplemented with 20 mg d-α-tocopherol acetate per day. Indices of IR were examined on study day 22, 30, 78, 85, 106, and 113. Addition of DHA at moderately high levels did not alter the proliferation of peripheral blood mononuclear cells cultured with phytohemag-glutinin or concanavalin A, or the delayed hypersensitivity skin response. Also, additional DHA did not alter the number of T cells producing interleukin 2 (IL2), the ratio between the helper/suppressor T cells in circulation, or the serum concentrations of immunoglobulin G, C3, and interleukin 2 receptor (IL2R). DHA supplementation, however, caused a significant (P=0.0001) decrease in the number of circulating white blood cells which was mainly due to a decrease in the number of circulating granulocytes. The number of lymphocytes in peripheral circulation was not affected by Dietary DHA enrichment, but the percentage of lymphocytes in white blood cells increased because of a reduction in granulocyte numbers. None of these indices was changed in the control group. Our results show that when total fat intake is low and held constant, DHA consumption does not inhibit many of the lymphocyte functions which have been reported to be inhibited by fish oil consumption.     

I2 as a mild and efficient catalyst in deoxygenation of sulfoxides with thioacetic acid

An effective procedure for deoxygenation of sulfoxides to sulfides using thioacetic acid as a reducing agent and a catalytic amount of I₂ in MeCN at ambient temperature has been developed. Using this protocol, a variety of sulfoxides including benzyl, allyl, alkyl and aryl sulfoxides have been successfully reduced to the corresponding sulfides in excellent yields.